MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crawford, K. W.
Right arrow Articles by Cote, T. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crawford, K. W.
Right arrow Articles by Cote, T. E.

Angiotensin II receptor recognized by DuP753 regulates two distinct guanine nucleotide-binding protein signaling pathways

KW Crawford, EA Frey and TE Cote

Uniformed Services University of the Health Sciences, Department of Pharmacology, Bethesda, Maryland 20889-4799.

The 7315c cell, derived from a rat anterior pituitary tumor, expresses an angiotensin II (AII) receptor. [3H]AII binds to 7315c membranes specifically and saturably (Kd = 2.1 +/- 0.6 x 10(-6) M, Bmax = 282 +/- 33 fmol/mg of protein). GTP diminished the affinity of the membranes for [3H]AII (Kd = 4.1 +/- 0.4 x 10(-9) M, Bmax = 210 +/- 26 fmol/mg of protein). [3H]AII binding was displaced by AII (Ki = 1.3 +/- 0.6 x 10(- 9) M), angiotensin III (AIII) (Ki = 0.9 +/- 0.4 x 10(-9) M), and the nonpeptide AII antagonist DuP753 (Ki = 1.4 +/- 0.6 x 10(-8) M). In contrast, a second nonpeptide AII ligand, PD123177, did not compete for [3H]AII binding sites. In intact cells, AII and AIII stimulated inositol trisphosphate (IP3) production (EC50 = 1.1 +/- 0.6 x 10(-8) M and 1.1 +/- 0.5 x 10(-8) M, respectively); this response to AII was antagonized by DuP753 (Ki = 1.7 +/- 0.3 x 10(-7) M). Pertussis toxin treatment failed to affect the ability of AII to stimulate IP3 production. In a crude membrane preparation, GTP was required for maximal AII-induced IP3 stimulation; guanosine thio-diphosphate abolished the agonist-GTP stimulation of IP3 production, in a concentration-dependent fashion. AII and AIII also inhibited adenylyl cyclase (EC50 = 2.9 +/- 1.1 x 10(-8) M and 6.0 +/- 1.0 x 10(-8) M, respectively). DuP753 antagonized the inhibition by AII of adenylyl cyclase (Ki = 2.8 +/- 0.4 x 10(-8) M). PD123177 failed to antagonize AII-induced cyclase inhibition. Pertussis toxin treatment abolished the AII and AIII inhibition of adenylyl cyclase. GTP was required for AII- induced inhibition of adenylyl cyclase. These data suggest that, in 7315c cells, a single subtype of AII receptor, identified by DuP753, is capable of regulating two different guanine nucleotide-binding protein (G protein) signalling pathways; one G protein, which is insensitive to pertussis toxin, stimulates IP3 production and the other G protein, which is sensitive to pertussis toxin, inhibits adenylyl cyclase.

Volume 41, Issue 1, pp. 154-162, 01/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Neurophysiol.Home page
Q. Chen and H.-L. Pan
Signaling Mechanisms of Angiotensin II-Induced Attenuation of GABAergic Input to Hypothalamic Presympathetic Neurons
J Neurophysiol, May 1, 2007; 97(5): 3279 - 3287.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Wei, S. Ahn, S. K. Shenoy, S. S. Karnik, L. Hunyady, L. M. Luttrell, and R. J. Lefkowitz
Independent {beta}-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2
PNAS, September 16, 2003; 100(19): 10782 - 10787.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. N. McLaughlin, C. D. Thulin, S. M. Bray, M. M. Martin, T. S. Elton, and B. M. Willardson
Regulation of Angiotensin II-induced G Protein Signaling by Phosducin-like Protein
J. Biol. Chem., September 13, 2002; 277(38): 34885 - 34895.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
M. de Gasparo, K. J. Catt, T. Inagami, J. W. Wright, and Th. Unger
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
Pharmacol. Rev., September 1, 2000; 52(3): 415 - 472.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. G. Teschemacher and E. P. Seward
Bidirectional Modulation of Exocytosis by Angiotensin II Involves Multiple G-Protein-Regulated Transduction Pathways in Chromaffin Cells
J. Neurosci., July 1, 2000; 20(13): 4776 - 4785.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Sano, K. Ohyama, Y. Yamano, Y. Nakagomi, S. Nakazawa, M. Kikyo, H. Shirai, J. S. Blank, J. H. Exton, and T. Inagami
A Domain for G Protein Coupling in Carboxyl-terminal Tail of Rat Angiotensin II Receptor Type 1A
J. Biol. Chem., September 19, 1997; 272(38): 23631 - 23636.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Mlinar, B. A. Biagi, and J. J. Enyeart
Losartan-sensitive AII Receptors Linked to Depolarization- dependent Cortisol Secretion through a Novel Signaling Pathway
J. Biol. Chem., September 8, 1995; 270(36): 20942 - 20951.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Shirai, K. Takahashi, T. Katada, and T. Inagami
Mapping of G Protein Coupling Sites of the Angiotensin II Type 1 Receptor
Hypertension, April 1, 1995; 25(4): 726 - 730.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
I. Leduc and S. Meloche
Angiotensin II Stimulates Tyrosine Phosphorylation of the Focal Adhesion-associated Protein Paxillin in Aortic Smooth Muscle Cells
J. Biol. Chem., March 3, 1995; 270(9): 4401 - 4404.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1992 by the American Society for Pharmacology and Experimental Therapeutics